IndiaTickerLatest filing: General Updates - Akums Drugs and Pharmaceuticals Limited
ObservedCompany dossier
Akums Drugs & Pharma
NSE:AKUMS · ISIN INE09XN01023
- Close
- ₹664.55 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Akums Drugs & Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,010.4 Cr · PAT ₹66.3 Cr.
Exchange XBRLLatest ownership: promoter group 75.26% and public 22.01% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Akums Drugs and Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Acquisition
BSE · exchange filing
Observed
Source filing Shareholders meeting - Akums Drugs and Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Akums Drugs and Pharmaceuticals Ltd - 544222 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,010.4 Cr
- Profit after tax
- ₹66.3 Cr
- EPS
- ₹4.26
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 75.26%
- Public
- 22.01%
- Employee trust
- 2.73%
Observed NSE shareholding XBRL